4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine has been researched along with fenfluramine in 1 studies
Studies (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Trials (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Recent Studies (post-2010) (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Studies (fenfluramine) | Trials (fenfluramine) | Recent Studies (post-2010) (fenfluramine) |
---|---|---|---|---|---|
42 | 0 | 9 | 3,112 | 478 | 222 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cremers, TI; de Boer, SF; Koolhaas, JM; Lieuwes, N; van der Vegt, BJ | 1 |
1 other study(ies) available for 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and fenfluramine
Article | Year |
---|---|
Cerebrospinal fluid monoamine and metabolite concentrations and aggression in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,7-Dihydroxytryptamine; Aggression; Animals; Biogenic Monoamines; Chromatography, High Pressure Liquid; Dopamine; Fenfluramine; Hydroxyindoleacetic Acid; Male; Norepinephrine; Piperazines; Pyridines; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |